Morbid obesity and outcome of ectopic pregnancy following capped single-dose regimen methotrexate

被引:0
作者
Luis R. Hoyos
Mokerrum Malik
Marvin Najjar
Javier Rodriguez-Kovacs
Mazen Abdallah
Gustavo Vilchez
Awoniyi O. Awonuga
机构
[1] Wayne State University/Hutzel Women’s Hospital,Department of Obstetrics and Gynecology
[2] Reproductive Endocrinology and Infertility,Division of Maternal
[3] Houston Fertility Services,Fetal Medicine
[4] Department of Obstetrics and Gynecology,Division of Reproductive Endocrinology and Infertility
[5] University of Missouri-Kansas City School of Medicine,undefined
[6] Department of Obstetrics and Gynecology,undefined
[7] Wayne State University/Hutzel Women’s Hospital,undefined
来源
Archives of Gynecology and Obstetrics | 2017年 / 295卷
关键词
Morbid obesity; Ectopic pregnancy; Capped dose; Methotrexate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:375 / 381
页数:6
相关论文
共 72 条
[1]  
Chang J(2003)Pregnancy-related mortality surveillance–United States, 1991–1999 MMWR Surveill Summ 52 1-8
[2]  
Elam-Evans LD(1982)The timing of a repeat ultrasound examination in the evaluation for ectopic pregnancy J Clin Ultrasound 10 211-214
[3]  
Berg CJ(1983)Combined use of serum HCG and sonography in the diagnosis of ectopic pregnancy AJR Am J Roentgenol 141 609-615
[4]  
Herndon J(2012)Medical management of ectopic pregnancy Clin Obstet Gynecol 55 424-432
[5]  
Flowers L(2000)Cost-effectiveness of single-dose methotrexate compared with laparoscopic treatment of ectopic pregnancy Obstet Gynecol 95 407-412
[6]  
Seed KA(2003)The medical management of ectopic pregnancy: a meta-analysis comparing “single dose” and “multidose” regimens Obstet Gynecol 101 778-784
[7]  
Syverson CJ(2005)Ectopic pregnancy Lancet 366 583-591
[8]  
Kadar N(2009)Clinical practice Ectopic pregnancy. N Engl J Med 361 379-387
[9]  
Romero R(1998)Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit? J Clin Oncol 16 2297-2298
[10]  
Kadar N(2012)Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults Pharmacotherapy 32 856-868